dismiss

Save the Date - Our next Clean Sweep Live Auction will be on Tuesday, September 26th at 9:30AM EST

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

MRI Homepage

PET/MR scans can asses pediatric cancer survivor health Study targets chemotherapy after-effects in young patients

FDA approves sale of SyMRI IMAGE software for GE Healthcare MR scanners Reduces scan times

FDA panel: Add retention warning to gadolinium contrast agents MIDAC also votes to increase studies conducted by contrast manufacturers

Study finds MR can measure kidney scarring and predict future kidney function Could also test new anti-scarring treatments

Resilience Capital Partners acquires three medical device service and manufacturing companies Forms Innovatus Imaging Corporation

Children’s National Health System first U.S. pediatric institution to use MR-HIFU Requires no incision

Doctors to apply for CT and MR scan permission under Anthem Aimed at reducing hospital outpatient imaging services

Imaging technology scans reveal trend in kidney cancer rates may be at an end Used CT, MRI, PET and ultrasound scans

MR isn't helpful for evaluating children with sports-related concussion symptoms Findings provide 'important guidance'

New MR technique on carotid plaques could predict risk of stroke Performs cardiovascular magnetic resonance scans

Researchers continue to look
for brain-based biomarkers

New guidelines advise against the use of brain imaging to diagnose chronic pain

by Lauren Dubinsky , Senior Reporter
A task force of researchers from around the world released new guidelines that recommend against the use of brain imaging to diagnose chronic pain.

With current imaging technology it’s impossible to determine whether a patient is experiencing chronic pain, according to Dr. Karen Davis, pain researcher at the Krembil Research Institute in Toronto, who led the task force. She argued that only the patient can provide that information, since pain is subjective.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory DOTmed Certified



Data from the Institute of Medicine of The National Academies revealed that 100 million Americans suffer from chronic pain. That’s more than the combined incidence of diabetes, coronary heart disease, stroke and cancer.

“Currently, physicians use a variety of approaches to decide on chronic pain treatments that relate to many medical and practical issues,” Davis told HCB News. “The method that is used is effective for some patients but not for many others.”

Physicians take into consideration the severity of the pain, other factors that accompany the pain, such as inflammation, other medical conditions the patient may have that prevent them from using some classes of drugs, the side effects of treatment, and what would be tolerable for the patient.

Recent advancements in brain imaging have led to a greater understanding of acute and chronic pain. That prompted a search for brain-based biomarkers for pain in order to offer patients more personalized treatment options.

Brain imaging is also in high demand among the legal community for use as a “lie detector” for chronic pain. Davis refers to that practice as inappropriate and unethical because pain varies between individuals and even within an individual at different times.

The new guidelines, which are published in the journal Nature Review: Neurology, state that any brain-based biomarkers should only be used as an adjunct to subjective reports of pain even if testing is improved and valid protocols are developed.

Davis and her team are working toward finding biomarkers for chronic pain to help provide more personalized treatment. The task force hopes the guidelines will be used by health care systems, governments, and legal policy makers as a blueprint for moving forward with research.

“Through brain imaging, we may be able to find particular features of the brain in some patients that are present when a particular treatment is effective, and other features that are present when that treatment is not,” said Davis. “Then, we would be able to match the patient to treatment.”

Back to HCB News
  Pages: 1

MRI Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED